|
1
|
Yamashita K, Sakuramoto S, Nemoto M,
Shibata T, Mieno H, Katada N, Kikuchi S and Watanabe M: Trend in
gastric cancer: 35 years of surgical experience in Japan. World J
Gastroenterol. 17:3390–3397. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Orditura M, Galizia G, Sforza V,
Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J,
Savastano B and Mabilia A: Treatment of gastric cancer. World J
Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee KE, Park JS, Khoi PN, Joo YE, Lee YH
and Jung YD: Upregulation of Recepteur d’origine Nantais tyrosine
kinase and cell invasiveness via early growth response-1 in gastric
cancer cells. J Cell Biochem. 113:1217–1223. 2012. View Article : Google Scholar
|
|
5
|
Wang MH, Lee W, Luo YL, Weis M and Yao HP:
Altered expression of the RON receptor tyrosine kinase in various
epithelial cancers and its contribution to tumourigenic phenotypes
in thyroid cancer cells. J Pathol. 213:402–411. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim S, Yoon TM, Lee DH, Park Y-L, Lee K-H,
Lim SC, Joo Y-E and Lee JK: RON (Recepteur d’origine Nantais)
expression and its association with tumor progression in laryngeal
squamous cell carcinoma. Auris Nasus Larynx. 41:201–206. 2014.
View Article : Google Scholar
|
|
7
|
Leonis MA, Thobe MN and Waltz SE:
Ron-receptor tyrosine kinase in tumorigenesis and metastasis.
Future Oncol. 3:441–448. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thangasamy A, Rogge J and Ammanamanchi S:
Recepteur d’origine Nantais tyrosine kinase is a direct target of
hypoxia-inducible factor-1α-mediated invasion of breast carcinoma
cells. J Biol Chem. 284:14001–14010. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park JS, Khoi PN, Joo YE, Lee YH, Lang SA,
Stoeltzing O and Jung YD: EGCG inhibits Recepteur d’origine Nantais
expression by suppressing Egr-1 in gastric cancer cells. Int J
Oncol. 42:1120–1126. 2013.PubMed/NCBI
|
|
10
|
Lin C-W, Chen P-N, Chen M-K, Yang W-E,
Tang C-H, Yang S-F and Hsieh Y-S: Kaempferol reduces matrix
metalloproteinase-2 expression by down-regulating ERK1/2 and the
activator protein-1 signaling pathways in oral cancer cells. PLoS
One. 8:e808832013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Calderon-Montano JM, Burgos-Morón E,
Pérez-Guerrero C and López-Lázaro M: A review on the dietary
flavonoid kaempferol. Mini Rev Med Chem. 11:298–344. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murakami A, Ashida H and Terao J:
Multitargeted cancer prevention by quercetin. Cancer Lett.
269:315–325. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin C-W, Hou W-C, Shen S-C, Juan S-H, Ko
C-H, Wang L-M and Chen Y-C: Quercetin inhibition of tumor invasion
via suppressing PKCδ/ERK/AP-1-dependent matrix metalloproteinase-9
activation in breast carcinoma cells. Carcinogenesis. 29:1807–1815.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakamura Y, Yogosawa S, Izutani Y,
Watanabe H, Otsuji E and Sakai T: A combination of indol-3-carbinol
and genistein synergistically induces apoptosis in human colon
cancer HT-29 cells by inhibiting Akt phosphorylation and
progression of autophagy. Mol Cancer. 8:1476–4598. 2009. View Article : Google Scholar
|
|
15
|
Kim SH, Kim SH, Kim YB, Jeon YT, Lee SC
and Song YS: Genistein inhibits cell growth by modulating various
mitogen-activated protein kinases and AKT in cervical cancer cells.
Ann NY Acad Sci. 1171:495–500. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin C-M, Shyu K-G, Wang B-W, Chang H, Chen
Y-H and Chiu J-H: Chrysin suppresses IL-6-induced angiogenesis via
down-regulation of JAK1/STAT3 and VEGF: an in vitro and in ovo
approach. J Agric Food Chem. 58:7082–7087. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lirdprapamongkol K, Sakurai H, Abdelhamed
S, Yokoyama S, Maruyama T, Athikomkulchai S, Viriyaroj A, Awale S,
Yagita H and Ruchirawat S: A flavonoid chrysin suppresses hypoxic
survival and metastatic growth of mouse breast cancer cells. Oncol
Rep. 30:2357–2364. 2013.PubMed/NCBI
|
|
18
|
Fu B, Xue J, Li Z, Shi X, Jiang B-H and
Fang J: Chrysin inhibits expression of hypoxia-inducible factor-1α
through reducing hypoxia-inducible factor-1α stability and
inhibiting its protein synthesis. Mol Cancer Ther. 6:220–226. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McKinsey TA, Brockman JA, Scherer DC,
Al-Murrani SW, Green PL and Ballard DW: Inactivation of IkappaBbeta
by the tax protein of human T-cell leukemia virus type 1: a
potential mechanism for constitutive induction of NF-kappaB. Mol
Cell Biol. 16:2083–2090. 1996.PubMed/NCBI
|
|
20
|
Geleziunas R, Ferrell S, Lin X, Mu Y,
Cunningham ET, Grant M, Connelly MA, Hambor JE, Marcu KB and Greene
WC: Human T-cell leukemia virus type 1 Tax induction of NF-κB
involves activation of the IκB kinase α (IKKα) and IKKβ cellular
kinases. Mol Cell Biol. 18:5157–5165. 1998.PubMed/NCBI
|
|
21
|
Snuderl M, Fazlollahi L, Le LP, Nitta M,
Zhelyazkova BH, Davidson CJ, Akhavanfard S, Cahill DP, Aldape KD
and Betensky RA: Mosaic amplification of multiple receptor tyrosine
kinase genes in glioblastoma. Cancer Cell. 20:810–817. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lemmon MA and Schlessinger J: Cell
signaling by receptor tyrosine kinases. Cell. 141:1117–1134. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou D, Pan G, Zheng C, Zheng J, Yian L
and Teng X: Expression of the RON receptor tyrosine kinase and its
association with gastric carcinoma versus normal gastric tissues.
BMC Cancer. 8:3532008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brechbuhl HM, Kachadourian R, Min E, Chan
D and Day BJ: Chrysin enhances doxorubicin-induced cytotoxicity in
human lung epithelial cancer cell lines: the role of glutathione.
Toxicol Appl Pharmacol. 258:1–9. 2012. View Article : Google Scholar :
|
|
25
|
Khan MS, Devaraj H and Devaraj N: Chrysin
abrogates early hepatocarcinogenesis and induces apoptosis in
N-nitrosodiethylamine-induced preneoplastic nodules in rats.
Toxicol Appl Pharmacol. 251:85–94. 2011. View Article : Google Scholar
|
|
26
|
Ahad A, Ganai AA, Mujeeb M and Siddiqui
WA: Chrysin, an anti-inflammatory molecule, abrogates renal
dysfunction in type 2 diabetic rats. Toxicol Appl Pharmacol.
279:1–7. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Samarghandian S, Afshari JT and Davoodi S:
Chrysin reduces proliferation and induces apoptosis in the human
prostate cancer cell line pc-3. Clinics. 66:1073–1079. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Khoo BY, Chua SL and Balaram P: Apoptotic
effects of chrysin in human cancer cell lines. Int J Mol Sci.
11:2188–2199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zandarashvili L, Vuzman D, Esadze A,
Takayama Y, Sahu D, Levy Y and Iwahara J: Asymmetrical roles of
zinc fingers in dynamic DNA-scanning process by the inducible
transcription factor Egr-1. Proc Natl Acad Sci USA.
109:E1724–E1732. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kwon O, Soung NK, Thimmegowda N, Jeong SJ,
Jang JH, Moon D-O, Chung JK, Lee KS, Kwon YT and Erikson RL:
Patulin induces colorectal cancer cells apoptosis through EGR-1
dependent ATF3 up-regulation. Cell Signal. 24:943–950. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kanazashi S, Hata D, Ishigami T, Jung EY,
Shintaku N, Sumimoto S, Heike T, Katamura K and Mayumi M: Induction
of phosphatidylinositol turnover and EGR-1 mRNA expression by
crosslinking of surface IgM and IgD in the human B cell line B104.
Mol Immunol. 31:21–30. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Perkins ND: Integrating cell-signalling
pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol.
8:49–62. 2007. View
Article : Google Scholar
|
|
33
|
Gilmore TD: Introduction to NF-κB:
players, pathways, perspectives. Oncogene. 25:6680–6684. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim S and Joo Y-E: Theaflavin inhibits
LPS-induced IL-6, MCP-1, and ICAM-1 expression in bone
marrow-derived macrophages through the blockade of NF-κB and MAPK
signaling pathways. Chonnam Med J. 47:104–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Narasimhan M and Ammanamanchi S: Curcumin
blocks RON tyrosine kinase-mediated invasion of breast carcinoma
cells. Cancer Res. 68:5185–5192. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ha SK, Moon E and Kim SY: Chrysin
suppresses LPS-stimulated proinflammatory responses by blocking
NF-κB and JNK activations in microglia cells. Neurosci Lett.
485:143–147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen C-C, Chow M-P, Huang W-C, Lin Y-C and
Chang Y-J: Flavonoids inhibit tumor necrosis factor-α-induced
up-regulation of intercellular adhesion molecule-1 (ICAM-1) in
respiratory epithelial cells through activator protein-1 and
nuclear factor-κB: structure-activity relationships. Mol Pharmacol.
66:683–693. 2004.PubMed/NCBI
|
